Molnupiravir: Heres’ what you need to know about Merck’s COVID-19 pill
As Merck and partner Ridgeback Biotherapeutics announced earlier this month that their pill Molnupiravir was… Read More
3 years ago
Merck
WHO says it awaits full data from Merck on COVID-19 pill molnupiravir
The World Health Organization is awaiting full clinical data on the antiviral pill made by… Read More
3 years ago
Merck applies for US authorization of COVID-19 pill
Merck & Co said on Monday it has applied for emergency use authorization in the… Read More
3 years ago
Merck and Singapore sign deal on COVID-19 antiviral pill
Pharmaceutical company Merck announced on Wednesday a supply and purchase agreement with Singapore that will… Read More
3 years ago
Merck’s COVID-19 pill cuts risk of death, hospitalization by 50%: study
Merck's experimental oral drug for COVID-19, molnupiravir, reduced by around 50% the chance of hospitalization… Read More
3 years ago
Five drugmakers to jointly start trial of Merck’s COVID-19 drug
Five Indian generic drugmakers, including Cipla and Dr Reddy's Laboratories, said on Tuesday they would… Read More
4 years ago
Merck says this drug causes quick reduction in coronavirus infection
The antiviral is being currently tested in a Phase 2/3 trial that is set to… Read More
4 years ago
Pasteur Institute, Merck abandon Covid-19 vaccine
The partners announced a tie-up last May to develop a jab based on an existing… Read More
4 years ago
Pharma giant Merck reveals COVID-19 vaccine plans
More than 100 vaccine candidates against SARS-CoV-2 are in development, with about 12 in human… Read More
5 years ago
Keytruda wins approval as combination therapy for kidney cancer
The drug was approved in combination with Pfizer’s Inlyta to treat advanced renal cell carcinoma. Read More
6 years ago
Germany’s Merck makes $5.9 billion counterbid for Versum
German drugs and lab supplies maker Merck KGaA offered $5.9 billion, including debt, for Versum… Read More
6 years ago
Merck, Pfizer drug combo extends kidney cancer survival: study
Merck on Monday released interim data from the trial, saying the combination reduced the risk… Read More
6 years ago
Merck to further study Keytruda in prostate cancer after early success
Merck & Co Inc said on Thursday it was launching three late-stage studies for its… Read More
6 years ago
Merck drug Keytruda succeeds in late-stage esophageal cancer trial
Merck & Co’s blockbuster drug Keytruda met the main goal of a late-stage trial testing… Read More
6 years ago
FDA puts hold on Merck multiple myeloma trials after deaths
Merck said on Wednesday the US Food and Drug Administration had placed a clinical hold… Read More
8 years ago